Why Is Trulieve Cannabis (NYSE:TRLV) Watching NYSE Composite?
Explore Trulieve Cannabis (NYSE:TRLV), operating across regulated cannabis markets, with insights into business operations, Florida presence, and the company’s role within the NYSE Composite.
Is Canopy Growth stock finally worth buying after losing 99% of its value?
A lower stock price doesn’t eliminate investment risk.
Tilray’s stock is down over 50% this year. Has it become a bargain buy?
The cannabis stock recently hit a new 52-week low.
Is Green Thumb stock oversold? The case for 100% upside.
It’s a rare gem among marijuana stocks, for several reasons.
The Easiest Way to Bet on US Cannabis Is This One ETF
One ETF promises investors a clean shot at the U.S. cannabis trade, but the inside of this fund is stranger than its simple ticker suggests.
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
The Easiest Way to Bet on US Cannabis Is This One ETF
One ETF promises investors a clean shot at the U.S. cannabis trade, but the inside of this fund is stranger than its simple ticker suggests.
DEA Rescheduling Hearing Puts Cannabis Stocks in Focus Ahead of a July 15 Deadline
The DEA’s cannabis rescheduling hearing runs through a July 15 deadline, putting cannabis stocks and the MSOS ETF in focus.
Innovative Industrial Properties: Cannabis Rescheduling Progress Reinforces The Re-Rating Thesis
Innovative Industrial’s AFFO was stable at $1.88/share, and leverage is still low for a REIT. Click here to read why IIPR stock is a Strong Buy.
3 reasons to buy Green Thumb Industries stock hand over fist
Green Thumb continues to execute while competitors struggle.
Calif. pot company skyrockets to $1B valuation following Trump action
This year has been a roller coaster for the massive California cannabis grower.
CRON strengthens global footprint: Is the cannabis stock worth buying?
Cronos Group CRON continues to attract investor attention as the cannabis company strengthens its global footprint and executes on several strategic initiatives. The company has been expanding its …
Trulieve’s NYSE listing is historic. But is the stock still worth buying?
The listing matters, but fundamentals matter more.
Jim Cramer on Trulieve Cannabis: “I Think It’s a Terrific Spec”
Trulieve Cannabis Corp. (NYSE:TRLV) was among the stocks on which Jim Cramer commented, as he emphasized that SpaceX investors are betting on Elon Musk rather than the company’s earnings. A caller …
Tilray Looks Cheap On The Surface, But Shareholders Still Need Proof
Tilray Brands is rated Hold, trading at a discounted 0.5–0.6x P/S due to persistent unprofitability and dilution risk. Learn more about TLRY stock here.
Recent Comments